Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer

Go back to Verrica Pharmaceuticals Appoints Chris Chapman as Chief Commercial Officer
(NASDAQ: VRCA) Delayed: 5.07 --0 (-0%)
Previous Close $5.07    52 Week High
Open $5.07    52 Week Low
Day High $5.07    P/E N/A 
Day Low $5.07    EPS
Volume 19